| Description | Lebrikizumab, an IgG4 humanized monoclonal antibody, specifically targets and inhibits interleukin-13 (IL-13), thus impacting its function. This compound is utilized in asthma research [1]. |
| molecular weight | N/A |
| CAS | 953400-68-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |